Total Payments
$446.43
2024 Payments
$23.05
Companies
15
Transactions
28
Medicare Patients
2,314
Medicare Billing
$608,851
Payment Breakdown by Category
Food & Beverage$446.43 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $446.43 | 28 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Shire North American Group Inc | $106.64 | 6 | $0 (2019) |
| Novo Nordisk Inc | $52.40 | 3 | $0 (2019) |
| Melinta Therapeutics, LLC | $48.90 | 3 | $0 (2021) |
| Daiichi Sankyo Inc. | $34.62 | 2 | $0 (2020) |
| Nestle HealthCare Nutrition Inc. | $31.19 | 2 | $0 (2021) |
| Lilly USA, LLC | $26.08 | 2 | $0 (2021) |
| VERTEX PHARMACEUTICALS INCORPORATED | $23.05 | 1 | $0 (2024) |
| Abbott Laboratories | $20.21 | 1 | $0 (2022) |
| Takeda Pharmaceuticals U.S.A., Inc. | $19.01 | 1 | $0 (2020) |
| Surmodics, Inc. | $18.04 | 2 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $23.05 | 1 | VERTEX PHARMACEUTICALS INCORPORATED ($23.05) |
| 2022 | $20.21 | 1 | Abbott Laboratories ($20.21) |
| 2021 | $88.20 | 7 | Surmodics, Inc. ($18.04) |
| 2020 | $81.60 | 5 | Takeda Pharmaceuticals U.S.A., Inc. ($19.01) |
| 2019 | $121.16 | 7 | Shire North American Group Inc ($74.22) |
| 2018 | $97.89 | 6 | Novo Nordisk Inc ($37.97) |
| 2017 | $14.32 | 1 | The Medicines Company ($14.32) |
All Payment Transactions
28 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/10/2024 | VERTEX PHARMACEUTICALS INCORPORATED | — | Food and Beverage | In-kind items and services | $23.05 | General |
| 11/07/2022 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $20.21 | General |
| Category: Diabetes Care | ||||||
| 11/18/2021 | Smith+Nephew, Inc. | PICO7 (Device), RENASYS GO | Food and Beverage | In-kind items and services | $11.12 | General |
| Category: Negative Pressure Wound Therapy | ||||||
| 09/28/2021 | Surmodics, Inc. | Pounce Thrombectomy System (Device), Sublime Balloon Dilatation Catheter | Food and Beverage | Cash or cash equivalent | $2.10 | General |
| Category: thrombectomy catheter | ||||||
| 09/20/2021 | Surmodics, Inc. | Pounce Thrombectomy System (Device), Sublime Balloon Dilatation Catheter | Food and Beverage | Cash or cash equivalent | $15.94 | General |
| Category: thrombectomy catheter | ||||||
| 06/13/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.31 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/27/2021 | Melinta Therapeutics, LLC | Orbactiv (Drug) | Food and Beverage | In-kind items and services | $16.11 | General |
| Category: ANTIBIOTICS | ||||||
| 05/19/2021 | Lilly USA, LLC | EMGALITY (Drug), TRULICITY | Food and Beverage | In-kind items and services | $14.74 | General |
| Category: Neuroscience | ||||||
| 03/11/2021 | Nestle HealthCare Nutrition Inc. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $13.88 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 12/15/2020 | Nestle HealthCare Nutrition Inc. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $17.31 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 09/22/2020 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $18.46 | General |
| Category: Anemia | ||||||
| 07/20/2020 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $11.34 | General |
| Category: Diabetes | ||||||
| 02/11/2020 | Boston Scientific Corporation | AMS (Device) | Food and Beverage | In-kind items and services | $15.48 | General |
| Category: ERECTILE DYSFUNCTION | ||||||
| 01/28/2020 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $19.01 | General |
| Category: IMMUNOLOGY | ||||||
| 11/13/2019 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $16.16 | General |
| Category: Anemia | ||||||
| 10/29/2019 | Shire North American Group Inc | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $19.80 | General |
| Category: IMMUNOLOGY | ||||||
| 09/24/2019 | Melinta Therapeutics, Inc. | Orbactiv (Drug), Baxdela | Food and Beverage | In-kind items and services | $16.35 | General |
| Category: ANTIBIOTICS | ||||||
| 08/30/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $14.43 | General |
| Category: Diabetes | ||||||
| 06/05/2019 | Shire North American Group Inc | NATPARA (PARATHYROID HORMONE) (Drug) | Food and Beverage | In-kind items and services | $16.86 | General |
| Category: INTERNAL MEDICINE | ||||||
| 05/07/2019 | Shire North American Group Inc | NATPARA (PARATHYROID HORMONE) (Drug) | Food and Beverage | In-kind items and services | $18.82 | General |
| Category: INTERNAL MEDICINE | ||||||
| 04/10/2019 | Shire North American Group Inc | NATPARA (PARATHYROID HORMONE) (Drug) | Food and Beverage | In-kind items and services | $18.74 | General |
| Category: INTERNAL MEDICINE | ||||||
| 09/11/2018 | Shire North American Group Inc | NATPARA (Drug) | Food and Beverage | In-kind items and services | $17.76 | General |
| Category: INTERNAL MEDICINE | ||||||
| 08/22/2018 | Shire North American Group Inc | NATPARA (Drug) | Food and Beverage | In-kind items and services | $14.66 | General |
| Category: INTERNAL MEDICINE | ||||||
| 08/09/2018 | Horizon Pharma plc | PENNSAID (Drug) | Food and Beverage | In-kind items and services | $11.06 | General |
| Category: PENNSAID | ||||||
| 05/25/2018 | Novo Nordisk Inc | Xultophy 100/3.6 (Drug), FIASP | Food and Beverage | In-kind items and services | $24.34 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 473 | 4,227 | $343,765 | $125,659 |
| 2022 | 9 | 597 | 4,835 | $415,165 | $153,238 |
| 2021 | 8 | 590 | 5,397 | $455,398 | $170,831 |
| 2020 | 9 | 654 | 5,368 | $483,686 | $159,124 |
Total Patients
2,314
Total Services
19,827
Medicare Billing
$608,851
Procedure Codes
32
All Medicare Procedures & Services
32 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 180 | 961 | $216,225 | $84,458 | 39.1% |
| 97032 | Application of electrical stimulation with therapist present, each 15 minutes | Office | 2023 | 81 | 2,407 | $60,175 | $21,216 | 35.3% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 75 | 612 | $36,720 | $9,418 | 25.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 64 | 64 | $19,200 | $7,004 | 36.5% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2023 | 53 | 156 | $7,800 | $1,927 | 24.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 20 | 27 | $3,645 | $1,636 | 44.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 200 | 1,161 | $261,225 | $102,196 | 39.1% |
| 97032 | Application of electrical stimulation with therapist present, each 15 minutes | Office | 2022 | 126 | 2,589 | $64,725 | $24,208 | 37.4% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 96 | 864 | $51,840 | $13,710 | 26.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 69 | 69 | $20,700 | $7,519 | 36.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 21 | 35 | $4,725 | $2,287 | 48.4% |
| 11042 | Removal of skin and tissue, 20.0 sq cm or less | Office | 2022 | 11 | 22 | $4,840 | $2,101 | 43.4% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2022 | 48 | 52 | $2,575 | $642.94 | 25.0% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 13 | 15 | $3,135 | $424.79 | 13.5% |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 2022 | 13 | 28 | $1,400 | $149.11 | 10.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 217 | 1,206 | $271,350 | $107,806 | 39.7% |
| 97032 | Application of electrical stimulation to 1 or more areas, each 15 minutes | Office | 2021 | 101 | 2,905 | $72,625 | $28,379 | 39.1% |
| 99211 | Established patient outpatient visit, minimal presenting problem | Office | 2021 | 103 | 1,044 | $62,640 | $16,972 | 27.1% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 79 | 79 | $23,700 | $8,843 | 37.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 35 | 64 | $8,640 | $4,486 | 51.9% |
| 11042 | Removal of skin and tissue first 20 sq cm or less | Office | 2021 | 14 | 33 | $7,260 | $3,172 | 43.7% |
| 20610 | Aspiration and/or injection of large joint or joint capsule | Office | 2021 | 27 | 37 | $7,733 | $998.73 | 12.9% |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 2021 | 14 | 29 | $1,450 | $172.50 | 11.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 228 | 1,260 | $283,500 | $94,987 | 33.5% |
| 97032 | Application of electrical stimulation to 1 or more areas, each 15 minutes | Office | 2020 | 113 | 2,707 | $67,675 | $26,475 | 39.1% |
About Dr. Arthur Flick, MD
Dr. Arthur Flick, MD is a Physical Medicine & Rehabilitation healthcare provider based in Clayton, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/15/2007. The National Provider Identifier (NPI) number assigned to this provider is 1952435828.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Arthur Flick, MD has received a total of $446.43 in payments from pharmaceutical and medical device companies, with $23.05 received in 2024. These payments were reported across 28 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($446.43).
As a Medicare-enrolled provider, Flick has provided services to 2,314 Medicare beneficiaries, totaling 19,827 services with total Medicare billing of $608,851. Data is available for 4 years (2020–2023), covering 32 distinct procedure/service records.
Ad
Practice Information
- Specialty Physical Medicine & Rehabilitation
- Other Specialties Orthopaedic Surgery
- Location Clayton, GA
- Active Since 03/15/2007
- Last Updated 03/12/2020
- Taxonomy Code 208100000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1952435828
Products in Payments
- NATPARA (PARATHYROID HORMONE) (Drug) $54.42
- Orbactiv (Drug) $48.90
- GLASSIA (Biological) $38.81
- INJECTAFER (Drug) $34.62
- NATPARA (Drug) $32.42
- ZENPEP (Drug) $31.19
- Xultophy 100/3.6 (Drug) $24.34
- FREESTYLE LIBRE 2 (Device) $20.21
- Pounce Thrombectomy System (Device) $18.04
- AMS (Device) $15.48
- EMGALITY (Drug) $14.74
- Ozempic (Drug) $14.43
- ORBACTIV (Drug) $14.32
- FARXIGA (Drug) $14.31
- Victoza (Drug) $13.63
- TRULICITY (Drug) $11.34
- PICO7 (Device) $11.12
- PENNSAID (Drug) $11.06
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.